Abiopharma

Clinical trial NCT07123090 updates: 1. completion date: 2028-02-01 → 2028-04-01 2. primary completion date: 2026-10-01 → 2027-10-01

Clinical trial NCT07712874: start date: 2026-08-24 → 2026-08-25.

Clinical trial NCT06505005 updates: 1. status: ENROLLING_BY_INVITATION → COMPLETED 2. completion date: 2026-05-01 → 2026-08-01 3. primary completion date: 2026-05-01 → 2026-08-01 4. enrollment type: ESTIMATED → ACTUAL

Clinical trial NCT04933903 updates: 1. completion date: 2026-09-01 → 2026-12-01 2. primary completion date: 2026-06-01 → 2026-10-01

Clinical trial NCT06794996 updates: 1. status: ACTIVE_NOT_RECRUITING → COMPLETED 2. completion date: 2026-12-30 → 2026-07-20 3. primary completion date: 2026-12-30 → 2026-07-20

Clinical trial NCT07630974: start date: 2026-07-02 → 2026-07-06.

Clinical trial NCT07673081 updates: 1. status: NOT_YET_RECRUITING → ACTIVE_NOT_RECRUITING 2. start date: 2026-06-20 → 2026-06-22 3. completion date: 2026-11-30 → 2026-09-30 4. primary completion date: 2026-11-30 → 2026-09-30

Clinical trial NCT05915728: enrollment: 404 → 410 participants.

Clinical trial NCT07222254 updates: 1. status: ACTIVE_NOT_RECRUITING → COMPLETED 2. completion date: 2026-07-20 → 2026-07-30 3. primary completion date: 2026-07-20 → 2026-07-30

Clinical trial NCT07158905: start date: 2026-06-23 → 2026-06-29.

Clinical trial NCT05039866 updates: 1. status: ENROLLING_BY_INVITATION → ACTIVE_NOT_RECRUITING 2. enrollment: 48 → 32 participants 3. enrollment type: ESTIMATED → ACTUAL

Clinical trial NCT06741644: enrollment: 660 → 800 participants.

Clinical trial NCT06001788: primary completion date: 2026-08-01 → 2026-12-01.

Clinical trial NCT04936308 updates: 1. status: ACTIVE_NOT_RECRUITING → COMPLETED 2. completion date: 2026-07-16 → 2026-07-02

Clinical trial NCT07706673: start date: 2026-08-03 → 2026-09-17.